Spearhead Capital Advisors’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
Other funds holding STAA
BC
PAI
GCM
EFM
Spearhead Capital Advisors's STAA Position: Q3 2022 in Review
Spearhead Capital Advisors sold out of STAAR Surgical (STAA) in Q3 2022, closing a stake of 3,508 shares — an estimated $249K sold.
Spearhead Capital Advisors first reported a position in STAA in Q1 2022 and held it in 2 quarters. The position peaked at $284K in Q1 2022. 305 funds tracked by Wall St. Rank hold STAA as of Q3 2022.
- Spearhead Capital Advisors reported no remaining STAAR Surgical position as of Q3 2022 after selling out during the quarter.
- Spearhead Capital Advisors sold 3,508 STAAR Surgical shares in Q3 2022, an estimated $249K.
- Spearhead Capital Advisors first reported a position in STAAR Surgical in Q1 2022 and held it in 2 quarters.
- Spearhead Capital Advisors's STAAR Surgical position peaked at $284K in Q1 2022.
- 305 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2022.
Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.